Item 2.02 Results of Operations and Financial Condition.
As ofDecember 31, 2021 ,Tricida, Inc. , (the "Company") had cash, cash equivalents and investments of approximately$150.6 million (unaudited). Because the Company's consolidated financial statements for the year endedDecember 31, 2021 have not yet been finalized or audited, the preliminary statement of the Company's cash, cash equivalents and investments as ofDecember 31, 2021 in this Item 2.02 is subject to change, and the Company's actual cash, cash equivalents and investments as ofDecember 31, 2021 may differ materially from this preliminary estimate. Accordingly, you should not place undue reliance on this preliminary estimate. Item 7.01 Regulation FD Disclosure. OnJanuary 10, 2022 , the Company intends to make a prerecorded presentation at theH.C. Wainwright BIOCONNECT Virtual Conference that provides a Company overview, business update and progress on the Company's key initiatives. OnJanuary 13, 2022 , the Company intends to make a presentation at the 40th AnnualJ.P. Morgan Healthcare Conference that provides a Company overview, business update and progress on the Company's key initiatives. A form of the Company's slide presentation to be used at theH.C. Wainwright BIOCONNECT Virtual Conference and theJ.P Morgan Healthcare Conference is being furnished as Exhibit 99.1 to this Current Report on Form 8-K, and a copy is available on the Company's website at IR.Tricida.com. The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly stated by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Company Presentation 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source